Context Therapeutics | SC 13G:超過5%持股股東披露文件-Avidity Partners Management LP(9.9%),Avidity Partners Management (GP) LLC(9.9%)等
Context Therapeutics | SC 13G:超過5%持股股東披露文件-Deep Track Capital, LP(9.89%),Deep Track Biotechnology Master Fund, Ltd.(9.89%)等
Context Therapeutics | 4:持股變動聲明-高管 Minai-Azary Jennifer Lynn
Context Therapeutics | 4:持股變動聲明-高管 Levit Alex C.
Context Therapeutics | 4:持股變動聲明-高管 Lehr Martin A.
Context Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Affinity Healthcare Fund, LP (EIN(2.06%),Affinity Asset Advisors, LLC (EIN(2.06%)
Context Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Martin Lehr(8.8%),Martin Lehr 2000 Trust(5.1%)等
Context Therapeutics | SC 13G:超過5%持股股東披露文件-Opaleye Management Inc.(5.14%)
Context Therapeutics | 4:持股變動聲明-董事 Kantoff Philip W.
Context Therapeutics | 4:持股變動聲明-董事 West Linda
Context Therapeutics | 4:持股變動聲明-董事 Stacey Jennifer Evans
Context Therapeutics | 4:持股變動聲明-董事 BERMAN RICHARD J
Context Therapeutics | 4:持股變動聲明
Context Therapeutics | 4:持股變動聲明
Context Therapeutics | 4:持股變動聲明
Context Therapeutics | 4:持股變動聲明
Context Therapeutics | SC 13G:超過5%持股股東披露文件-Martin Lehr(7.3%),Martin Lehr 2000 Trust(5.1%)等
Context Therapeutics | 4:持股變動聲明
Context Therapeutics | 4:持股變動聲明
Context Therapeutics | 4:持股變動聲明
暫無數據